Massimo Breda
Impact in
- Analytical Chemistry top 5%
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery
Papers in
-
- Pharmacogenetics and Drug Metabolism 5
- Antibiotics Pharmacokinetics and Efficacy 4
-
- Biosimilars and Bioanalytical Methods 9
- Co-authors
- Christopher A. James (7 shared papers)Christopher A. James (2 shared papers)Daniela Fraier (2 shared papers)Margherita Strolin Benedetti (5 shared papers)E. Pianezzola (4 shared papers)Enrico Frigerio (6 shared papers)Alberto Emilio Panerai (3 shared papers)Gianfranco Fonte (2 shared papers)
- Journals
- Journal of Pharmaceutical and Biomedical Analysis (8 papers)Bioanalysis (5 papers)Chromatographia (3 papers)Pharmacological Research (2 papers)Journal of Chromatography A (2 papers)
- Partner nations
- ItalyUnited StatesUnited Kingdom
In The Last Decade
Massimo Breda
37 papers receiving 768 citations
Peers
Comparison fields: 5 of 92
- Analytical Chemistry 92
- Biomaterials 112
- Spectroscopy 138
- Immunology 144
- Oncology 144
Countries citing papers authored by Massimo Breda
This map shows the geographic impact of Massimo Breda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Massimo Breda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Massimo Breda more than expected).
Fields of papers citing papers by Massimo Breda
This network shows the impact of papers produced by Massimo Breda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Massimo Breda. The network helps show where Massimo Breda may publish in the future.
Co-authors
The 25 scholars most cited alongside Massimo Breda, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 38 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2002 | 103 | |
| 2 | 2005 | 68 | |
| 3 | 2005 | 51 | |
| 4 | 1991 | 43 | |
| 5 | 2003 | 42 | |
| 6 | 2003 | 40 | |
| 7 | 2010 | 40 | |
| 8 | 1990 | 39 | |
| 9 | 2012 | 39 | |
| 10 | 2012 | 33 | |
| 11 | 2004 | 30 | |
| 12 | 2012 | 29 | |
| 13 | 1996 | 29 | |
| 14 | 2017 | 26 | |
| 15 | 2011 | 25 | |
| 16 | Phase I clinical and pharmacokinetic study of 3'-deamino-3'-(2-methoxy-4-morpholinyl)doxorubicin (FCE 23762). | 1995 | 24 |
| 17 | 2004 | 19 | |
| 18 | 2008 | 19 | |
| 19 | 2012 | 19 | |
| 20 | 1993 | 18 |
About Massimo Breda
Massimo Breda is a scholar working on Pharmacology, Immunology, Oncology, Physiology and Spectroscopy, having authored 38 papers that have together received 849 indexed citations. Recurring topics across this work include Biosimilars and Bioanalytical Methods (9 papers), Analytical Chemistry and Chromatography (5 papers), Pharmacogenetics and Drug Metabolism (5 papers), Cancer Treatment and Pharmacology (4 papers), Cancer therapeutics and mechanisms (4 papers), Antibiotics Pharmacokinetics and Efficacy (4 papers), Clinical Laboratory Practices and Quality Control (4 papers) and Statistical Methods in Clinical Trials (3 papers). The work is most often cited by research in Analytical Chemistry (92 citations), Biomaterials (112 citations), Spectroscopy (138 citations), Immunology (144 citations) and Oncology (144 citations). Massimo Breda has collaborated with scholars based in Italy, United States and United Kingdom. Frequent co-authors include Christopher A. James, Christopher A. James, Daniela Fraier, Margherita Strolin Benedetti, E. Pianezzola, Enrico Frigerio, Alberto Emilio Panerai, Gianfranco Fonte, Pier Luigi Meroni and Paola Sacerdote. Their work appears in journals such as Journal of Pharmaceutical and Biomedical Analysis, Bioanalysis, Chromatographia, Pharmacological Research and Journal of Chromatography A.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.